An Inside Look at Angelman Syndrome Rare Disease with Advocate Amanda Moore

 

About this Podcast: 

In this episode, Amanda Moore, CEO of Angelman Syndrome Foundation speaks with Steve Smith, WCG’s President of Patient Advocacy. As a mom whose son has been diagnosed with Angelman Syndrome - a rare neuro-genetic disorder that affects 1 in 15,000 children - Amanda walks through the time from receiving initial diagnosis to the odyssey of her son’s patient journey in therapy and clinical trials.

About the Author

Steve Smith | President, Patient Advocacy, WCG

Steve Smith is a seasoned patient advocate with an extensive career in software, consulting, process transformation, health care systems and patient-focused drug development. He joined WCG as President Patient Advocacy in 2019 inspired by the incredible value to patients embedded in the wide range of WCG solutions that reduce the time and cost of clinical trials.

Visit Website More Content by Steve Smith | President, Patient Advocacy, WCG
Previous Post
A Father’s Journey and Fight Towards a Cure for MPS I Rare Disease
A Father’s Journey and Fight Towards a Cure for MPS I Rare Disease

Next Post
Developing Novel Treatments for Rare Disorders: A Look at MPS I with Dr. Emil Kakkis
Developing Novel Treatments for Rare Disorders: A Look at MPS I with Dr. Emil Kakkis